InvestorsHub Logo
icon url

CTMedic

12/12/20 9:05 AM

#133120 RE: Badge04 #133119

Badge04,

This is the contact information for Dr. Lalezari and Quest. I believe they review pathology studies for over expressed CCR5 and trial inclusion.

Good luck to you and your friend.

Quest Clinical Research
New Patient Coordinators:
Jamie Streit at (415) 353-0800
Emily Jennings at (415) 353-0800

Patient referrals directly to:
Jacob P. Lalezari, M.D.
Main telephone: (415) 353-0800
2300 Sutter Street, Suite 208
San Francisco, CA 94115

Northwest biopharmaceuticals has a late stage (locked phase 3 trial data waiting readout) glioblastoma treatment. I don’t know if their therapy is available compassionate use, but worth investigating as well.